Skip to main content
Premium Trial:

Request an Annual Quote

Incyte Expands Roche and AstraZeneca Partnerships


PALO ALTO, Calif.--Incyte Pharmaceuticals announced the expansion and extension of its agreements with Hoffmann-La Roche and AstraZeneca, continuing deals that were originally signed in 1996. AstraZeneca's expanded arrangement will include access to Incyte's LifeSeq Gold database of human gene sequence and expression data, its ZooSeq animal model database, and additional genomic databases and services. The Roche agreement grants access to LifeSeq Gold, ZooSeq, and continued access to the LifeSeq Atlas mapping database in exchange for annual access fees. In addition, Incyte could receive future milestone payments and royalties on sales of products developed with Incyte technology and database information. Financial terms for both agreements were not disclosed. The combination of the ZooSeq and the LifeSeq Gold databases enable scientists to make comparisons between human and animal pathways, Incyte said.

Filed under

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.